Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alison Felipe Bordini Biggi
Inhibition of PD-1 Protein by the CRISPR-Cas9 Method as Antitumor Therapy of Non-Small Cell Lung Cancers
Revista da Faculdade de Ciências Médicas de Sorocaba
Related publications
PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-Crispr Proteins
Molecular Cell
Cell Biology
Molecular Biology
P3.09-05 Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P013 Anti-Pd-1 Combination Therapy as Second Line Treatment or Beyond in Patients With Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Mechanisms of P16INK4A Inactivation in Non Small-Cell Lung Cancers
Oncogene
Cancer Research
Genetics
Molecular Biology
Inhibition of Long Non-Coding RNA UCA1 by CRISPR/Cas9 Attenuated Malignant Phenotypes of Bladder Cancer
Oncotarget
Oncology
Real-World Evidenceand Clinical Observations of the Treatment of Advanced Non-Small Cell Lung Cancer With PD-1/PD-L1 Inhibitors
Scientific Reports
Multidisciplinary
Hot Spot Mutations in Finnish Non-Small Cell Lung Cancers
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Feasibility of Continuing Crizotinib Therapy After RECIST-PD in Advanced Non-Small Cell Lung Cancer Patients With ALK/ROS-1 Mutations
Journal of Cancer
Oncology